Literature DB >> 11150289

Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features.

N Yuki1, M Odaka, K Hirata.   

Abstract

OBJECTIVE: To examine the clinical features of acute ophthalmoparesis (AO) (without ataxia) associated with anti-GQ1b immunoglobulin G (IgG) antibody.
DESIGN: Retrospective observational case series. PARTICIPANTS: Twenty-one subjects with AO (without ataxia) who had anti-GQ1b IgG.
METHODS: Clinical features of 21 subjects with AO were analyzed.
RESULTS: Seventeen had symptoms of antecedent infection. Gaze limitation was bilateral in 16 subjects and unilateral in five, indicative that laterality does not always negate AO. Nine subjects showed abducens paresis, and two limitation of abduction and adduction. Eight, who initially had bilateral abducens palsy, subsequently had impairment of adduction and vertical movement. These showed that bilateral abducens palsy followed by oculomotor nerve involvement is characteristic of AO. Muscle stretch reflexes were normal in nine subjects, hypoactive in eight, absent in three, and brisk in one. Distal paresthesias were present in seven subjects. Acellular cerebrospinal fluid (CSF) associated with raised protein concentration was detected in three.
CONCLUSIONS: Antecedent infectious symptoms, characteristic limitation of ocular movement, areflexia, distal paresthesias, and CSF albuminocytologic dissociation are useful markers for diagnosing AO as well as anti-GQ1b IgG. AO can be considered a mild form of Miller Fisher syndrome or a regional variant of Guillain-Barré syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11150289     DOI: 10.1016/s0161-6420(00)00420-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  20 in total

1.  Fisher syndrome.

Authors:  Masahiro Mori; Satoshi Kuwabara
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

2.  The Role of Botulinum Toxin in the Management of Ophthalmoplegia Secondary to Miller Fisher Syndrome.

Authors:  Siegfried K Wagner; Nabil Uddin; Saurabh Jain
Journal:  Neuroophthalmology       Date:  2017-08-18

3.  Late Presentation of Ataxia, Areflexia, and Electrophysiological Abnormalities as Part of Miller Fisher Syndrome: Case Report.

Authors:  Deniz Somer; Arzu Yilmaz; Serap Tiras Teber; Fatma Gul Cinar
Journal:  Neuroophthalmology       Date:  2016-06-08

4.  Unilateral third nerve palsy caused by Guillain-Barré Syndrome.

Authors:  Erik K St Louis; Daniel M Jacobson
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

5.  Pupillary Involvement in Miller Fisher Syndrome.

Authors:  Bahar Kaymakamzade; Ferda Selcuk; Aydan Koysuren; Ayse Ilksen Colpak; Senem Ertugrul Mut; Tulay Kansu
Journal:  Neuroophthalmology       Date:  2013-05-31

6.  Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis.

Authors:  E Ece Boylu; R Erdem Toğrol; Mehmet Güney Senol; M Fatih Ozdağ; Mehmet Saraçoğlu
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

7.  Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi.

Authors:  Y L Lo; L L Chan; A Pan; P Ratnagopal
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

8.  Polyneuritis cranialis--subtype of Guillain-Barré syndrome?

Authors:  Benjamin R Wakerley; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

Review 9.  Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barré syndrome.

Authors:  Benjamin R Wakerley; Nobuhiro Yuki
Journal:  J Neurol       Date:  2015-02-26       Impact factor: 4.849

Review 10.  Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Authors:  Benjamin R Wakerley; Antonino Uncini; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.